Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase - Test2 - elhamkhani - TriplyDB

Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase

Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase

http://www.wikidata.org/entity/Q28473067

about

A secreted tyrosine kinase acts in the extracellular environment Purinergic signalling and cancer Stable isotope-resolved metabolomics and applications for drug development CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression Ectonucleotidases in tumor cells and tumor-associated immune cells: an overview The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.Stanniocalcin-1 regulates extracellular ATP-induced calcium waves in human epithelial cancer cells by stimulating ATP release from bystander cells P2X ion channel receptors and inflammation Damage-associated molecular patterns in cancer: a double-edged sword Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents Danger signals, inflammasomes, and the intricate intracellular lives of chlamydiae P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients P2X7 targeting inhibits growth of human mesothelioma Multidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5'-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic Drugs Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization.The role of nucleotides in apoptotic cell clearance: implications for disease pathogenesis.A hyperpolarized equilibrium for magnetic resonance Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis.Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.The purine receptor P2X7R regulates the release of pro-inflammatory cytokines in human craniopharyngioma.The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP.ATP-P2Y2-β-catenin axis promotes cell invasion in breast cancer cells Carcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells.Remodeling of purinergic receptor-mediated Ca2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells Basal release of ATP: an autocrine-paracrine mechanism for cell regulation.Immune cell regulation by autocrine purinergic signalling.Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma.The hyposensitive N187D P2X7 mutant promotes malignant progression in nude mice.Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells.Brilliant blue FCF as an alternative dye for saphenous vein graft marking: effect on conduit function P2X receptors: New players in cancer pain.Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17 P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell MDA-MB-231 contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment.P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death.Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice.P2X7 receptor activation impairs exogenous MHC class I oligopeptides presentation in antigen presenting cells.Extracellular metabolic energetics can promote cancer progression The Warburg effect: evolving interpretations of an established concept

P2860

Q24303065-640ABDCC-B918-4637-AE19-C17B6F18A930 Q24618782-D8F836C1-9B0B-4062-9879-A58A694E2382 Q24629149-FA595550-694B-44CA-9DDF-A219BCA9A0F6 Q26801436-D023E7AF-E20E-4B5E-B75C-8AD24131C77D Q27002950-01B41E99-025D-4009-BDA0-89B14F3057F6 Q27304392-547B5541-E296-4616-9C1F-A559022CE458 Q27331304-0BDD625F-A204-4C8B-B053-94A3709C0832 Q28066934-A04023AF-0FF4-47BE-8336-2E2021B02E0A Q28067434-AAC6E198-0FF9-4941-ADC7-1CE68B7215C7 Q28073524-835DCCE6-AAFA-4254-A83E-F81BE8013107 Q28076278-EE1BCC4E-4C1B-4F56-BD95-0791486C24BC Q28386398-DAE1C446-DDFE-45B7-9482-11C8D7F95048 Q28468633-E586D107-3AB3-47C6-BB7E-63DAD6B018A2 Q28547426-882509A6-8143-42A6-A851-C730D757718E Q29615615-13A469C3-F439-4D1D-8E48-B67CE16C5833 Q30409620-F2B9D379-146C-431F-9D8B-5CA8D92C251A Q30429149-630EB536-6966-4DF1-A523-40745D0D8A94 Q30714562-4666F6E6-62E0-4ECA-8056-A4B44DA737EA Q31171730-DDA7B163-2F78-41D6-A021-EEFF12DF7165 Q33667612-8654E550-367F-420C-8AFE-52D9C4824B24 Q33759124-AF727671-4E69-47E7-B113-1281A8AC3CC3 Q33846541-9C0FD628-3E33-49B7-B6D0-6F30C9EFCC02 Q33873659-F7A7BD29-8C50-4E33-8945-9CE5EAF19172 Q33913908-126DBF1E-8E12-471E-AAE6-B40BE4A4C2B0 Q33995723-21C366CA-FA72-4A4A-9D72-FC2B7D77106F Q34020834-0D7C9727-2403-462E-8B5D-E6A172CD2FA6 Q34025783-35B700DE-91F7-4264-94EA-D6E749DC7026 Q34195588-C4B749FE-C7B8-45E7-A7BC-0E845B5E4CA8 Q34285496-2CBF6EFC-903E-4519-8AF5-95590C11E7C2 Q34359969-DA76B556-58C5-4507-9DCE-577DF7FF810C Q34504024-2D76A807-22F8-4F09-B135-6672ACD8778D Q34543538-6A237AB6-843A-4E0B-B57D-ED082EB6A090 Q34567944-515E1FDE-9B44-4F61-B51A-4DD8A88AF599 Q34575695-DB5634F1-A300-48AE-BE94-97081072E4B1 Q34619350-64B063D4-5F68-4657-A449-E7E95B800525 Q34658181-A3E01448-A807-4EDD-9736-D940DD75FB0E Q34695338-36D3C549-DF92-4FD5-B879-D5F6F793CEB6 Q34935396-3E96F2F9-2514-4954-9F74-77ED9D62CB0A Q35033532-1899D40D-8BBE-4438-AF1F-F57F06E62A0D Q35169587-BC519564-8575-4BD4-84DE-07B6B63089C3

P2860

Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase

http://www.wikidata.org/entity/Q28473067

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Increased level of extracellul ...... ith plasma membrane luciferase

@ast

Increased level of extracellul ...... ith plasma membrane luciferase

@en

Increased level of extracellul ...... ith plasma membrane luciferase

@nl

type

label

Increased level of extracellul ...... ith plasma membrane luciferase

@ast

Increased level of extracellul ...... ith plasma membrane luciferase

@en

Increased level of extracellul ...... ith plasma membrane luciferase

@nl

prefLabel

Increased level of extracellul ...... ith plasma membrane luciferase

@ast

Increased level of extracellul ...... ith plasma membrane luciferase

@en

Increased level of extracellul ...... ith plasma membrane luciferase

@nl

P1433

Q28473067-137F7CF6-1DB8-4A25-AF49-492B526700EE

P1476

Q28473067-9456A574-DBE1-4B37-8A73-FAF232E81EB6

P2093

Q28473067-9501220A-2555-46E9-AA55-967E9D3574DA

Q28473067-D1F335C1-F156-4A08-9844-A832E153541C

Q28473067-DFB54E16-CB86-488F-B368-6C5596F5EE8F

P2860

Q28473067-131A0F15-41ED-4F25-833F-FB8A82DA037D

Q28473067-2ADB84ED-55F4-4DAF-ABDD-2850EBC8502A

Q28473067-31C0BBE3-39A6-459C-9188-A816A214D9A3

Q28473067-3DCCC042-9D72-4A59-A425-8D2EE91F4EF1

Q28473067-49BF7B27-17ED-4094-BF84-5827EA621E32

Q28473067-4C90030E-A8A1-446A-9540-99F537AF05C0

Q28473067-4D0D8FAA-D12E-4486-8CB3-61E8793CE30A

Q28473067-4FED142C-7A8E-4DFA-8AEF-CB288C9A8807

Q28473067-5CFE2889-AA75-45BC-89C7-728AD914643C

Q28473067-6A30C667-340F-4FCC-8E03-D2BF8723B3D1

P304

Q28473067-8D1F780A-3CD1-4B26-8E42-F4C6A447C06A

P31

Q28473067-A3ED1757-EF03-41B3-889A-5300E4D596DB

P3181

Q28473067-C455427A-1097-4B30-97CE-238FA6B69558

P356

Q28473067-7EA2D381-6CD8-4997-BAF0-8AB4AD9729BE

P407

Q28473067-F1F8DA38-C6A5-4E30-8112-09388AD58F6D

P433

Q28473067-A1F44711-0C7D-40D3-A99C-06894524022A

P478

Q28473067-C4C56CD4-473E-4F0C-896A-3F1C36B44B1A

P50

Q28473067-8881277F-8BF4-4A12-890E-B90289802065

Q28473067-CA05C045-2F7D-41DB-B485-C0057F705650

Q28473067-EA167A8C-2D45-40B3-B6D5-7A70016C6C27

P577

Q28473067-75D3D9CE-CB66-4BEE-9563-CCBA351413D6

P5875

Q28473067-F8E9089F-03AA-46D5-A026-9836FC2D3A1D

P698

Q28473067-5E647820-45A2-448A-BEE8-405B5A91AE8A

P932

Q28473067-3E044E9B-51D6-4D33-B8AA-05FAD009047C

P3181

P356

JOURNAL.PONE.0002599

P1433

P1476

Increased level of extracellul ...... ith plasma membrane luciferase

@en

P2093

Federica Piccardi

http://www.w3.org/2001/XMLSchema#string

Patrizia Pellegatti

http://www.w3.org/2001/XMLSchema#string

Vito Pistoia

http://www.w3.org/2001/XMLSchema#string

P2860

Shaping of monocyte and macrophage function by adenosine receptors

A perivascular niche for brain tumor stem cells

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.

Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?

A cytokine-mediated link between innate immunity, inflammation, and cancer.

A2A adenosine receptor protects tumors from antitumor T cells.

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

Growth regulation of the vascular system: an emerging role for adenosine.

Release of ATP in the central nervous system during systemic inflammation: real-time measurement in the hypothalamus of conscious rabbits.

P304

e2599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1500293

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0002599

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Lizzia Raffaghello

Francesco Di Virgilio

Giovanna Bianchi

P577

2008-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5239189

http://www.w3.org/2001/XMLSchema#string

P698

18612415

http://www.w3.org/2001/XMLSchema#string

P932

2440522

http://www.w3.org/2001/XMLSchema#string